Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...
Obesity is a chronic medical condition that affects millions of people worldwide. And while BMI (body mass index) is not the ...
The researchers compared the drugs to bupropion-naltrexone, the active ingredient in weight-loss drug Contrave, which was approved in 2014. A Novo Nordisk spokesperson noted that some of the ...